Cart
sales@molnova.com
Phyllanthin
CAS No. 10351-88-9
Phyllanthin( —— )
Catalog No. M23242 CAS No. 10351-88-9
Phyllanthin is widely used as hepatoprotective and antigenotoxic and inhibit function of P-gp.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 129 | In Stock |
|
| 10MG | 191 | In Stock |
|
| 25MG | 322 | In Stock |
|
| 50MG | 475 | In Stock |
|
| 100MG | 680 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePhyllanthin
-
NoteResearch use only, not for human use.
-
Brief DescriptionPhyllanthin is widely used as hepatoprotective and antigenotoxic and inhibit function of P-gp.
-
DescriptionPhyllanthin is widely used as hepatoprotective and antigenotoxic and inhibit function of P-gp.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayApoptosis
-
TargetNF-κB
-
RecptorNF-κB
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number10351-88-9
-
Formula Weight418.5
-
Molecular FormulaC24H34O6
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 62.5 mg/mL (149.34 mM)
-
SMILESCOC[C@@H](CC1=CC=C(OC)C(OC)=C1)[C@@H](COC)CC2=CC=C(OC)C(OC)=C2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Phyllanthin and hypophyllanthin inhibit function of P-gp but not MRP2 in Caco-2 cells.J Pharm Pharmacol. 2013 Feb;65(2):292-9.
molnova catalog
related products
-
Stachydrine
Stachydrine is a major constituent of Chinese herb leonurus heterophyllus sweet used to promote blood circulation and dispel blood stasis. Stachydrine can inhibit the NF-κB signal pathway. Stachydrine is a biomarker for the consumption of citrus fruits.
-
Lipoic acid
A multifunction antioxidant that has growth promoting, anti-inflammatory, antioxidative, immunostimulatory, and hypocholesterolemic properties.
-
Tomatidine
Tomatidine decreases inducible NO synthase and COX-2 expression through suppression of I-κBα phosphorylation, NF-κB nuclear translocation and JNK activation, which in turn inhibits c-jun phosphorylation and Oct-2 expression.
